Adult Surviving Sepis Campaign Guidelines (Hour-1 Bundle)
Children's Surviving Sepsis Campaign Guidelines
Adult ICU Liberation Guidelines and Bundle (A-F)
Management of Adults with COVID-19
New User? Sign Up Free
SCCM is updating its SCCM Connect Community. Access to SCCM Connect may be limited until April 23.
Maresa D. Glass, PharmD, BCPS, BCCCP
In November 2017, The Society of Critical Care Medicine (SCCM) participated in a meeting of healthcare professional organizations, the American Hospital Association (AHA), the U.S. Food and Drug Administration (FDA), and the Department of Health and Human Services (HHS) to address the ongoing patient care challenges associated with drug product shortages. Held at the American Society of Health-System Pharmacists’ headquarters, the groups represented in large part the clinician community, but also included the AHA, the Pew Charitable Trusts, and the University of Utah Drug Information Services. Representatives of the American Society of Anesthesiologists, American Society of Clinical Oncology, American Medical Association, American Society for Parenteral and Enteral Nutrition, Institute for Safe Medication Practices, and SCCM discussed the ongoing challenges of drug shortages and their impact on patient care.
The group discussion focused on answering the following three questions: